Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Okami

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Head & Neck|January 24, 2020
Central pathology review of salivary gland adenoid cystic carcinomaKaori Ueda, Takayuki Murase, Toshitaka Nagao, et al.
Oncotarget|November 29, 2016
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in JapanDaisuke Kawakita, Yuichiro Tada, Yorihisa Imanishi, et al.
Nature Medicine|March 23, 2004
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancerZhongmin Guo, Jürgen F Linn, Guojun Wu, et al.
Oncotarget|September 24, 2017
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classificationSoichiro Takase, Satoshi Kano, Yuichiro Tada, et al.
Histopathology|July 12, 2018
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 casesMakoto Urano, Hideaki Hirai, Yuichiro Tada, et al.
Virchows Archiv : an International Journal of Pathology|July 18, 2023
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinomaHideaki Hirai, Masato Nakaguro, Yuichiro Tada, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2025
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 VariantsYoshitaka Utsumi, Masato Nakaguro, Daisuke Kawakita, et al.
Oncotarget|February 9, 2018
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomasTomotaka Shimura, Yuichiro Tada, Hideaki Hirai, et al.
Virchows Archiv : an International Journal of Pathology|February 28, 2020
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinomaHideaki Hirai, Yuichiro Tada, Masato Nakaguro, et al.
Virchows Archiv : an International Journal of Pathology|July 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinomaManami Kajiwara, Hideaki Takahashi, Masato Nakaguro, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Head & Neck|January 24, 2020
Central pathology review of salivary gland adenoid cystic carcinomaKaori Ueda, Takayuki Murase, Toshitaka Nagao, et al.
Oncotarget|November 29, 2016
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in JapanDaisuke Kawakita, Yuichiro Tada, Yorihisa Imanishi, et al.
Nature Medicine|March 23, 2004
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancerZhongmin Guo, Jürgen F Linn, Guojun Wu, et al.
Oncotarget|September 24, 2017
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classificationSoichiro Takase, Satoshi Kano, Yuichiro Tada, et al.
Histopathology|July 12, 2018
The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 casesMakoto Urano, Hideaki Hirai, Yuichiro Tada, et al.
Virchows Archiv : an International Journal of Pathology|July 18, 2023
Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinomaHideaki Hirai, Masato Nakaguro, Yuichiro Tada, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 9, 2025
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 VariantsYoshitaka Utsumi, Masato Nakaguro, Daisuke Kawakita, et al.
Oncotarget|February 9, 2018
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomasTomotaka Shimura, Yuichiro Tada, Hideaki Hirai, et al.
Virchows Archiv : an International Journal of Pathology|February 28, 2020
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinomaHideaki Hirai, Yuichiro Tada, Masato Nakaguro, et al.
Virchows Archiv : an International Journal of Pathology|July 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinomaManami Kajiwara, Hideaki Takahashi, Masato Nakaguro, et al.
Pageof 13